Jon B Bishop, MD | |
700 W 800 N, Suite 442, Orem, UT 84057-6301 | |
(801) 802-0120 | |
(801) 802-0121 |
Full Name | Jon B Bishop |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 700 W 800 N, Orem, Utah |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1609818616 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2082S0105X | Plastic Surgery - Surgery Of The Hand | 3624831205 (Utah) | Primary |
Mailing Address | Practice Location Address |
---|---|
Jon B Bishop, MD 700 W 800 N, Suite 442, Orem, UT 84057-6301 Ph: (801) 802-0120 | Jon B Bishop, MD 700 W 800 N, Suite 442, Orem, UT 84057-6301 Ph: (801) 802-0120 |
News Archive
TCF Bank, in its efforts to provide crucial support to Minnesota's frontline health care workers and accelerate innovations directed at tackling the COVID-19 health crisis, has announced a $100,000 match incentive program in collaboration with University of Minnesota Emergency Fund for Covid-19 response.
Once it has begun to spread in the body, approximately half of patients with an aggressive breast cancer type will develop cancer in the brain. Researchers at the University of North Carolina Lineberger Comprehensive Cancer Center want to improve treatment for patients with breast cancer brain metastases, but using the body's existing defenses - the immune system.
Researchers from Florida Atlantic University's College of Engineering and Computer Science, in collaboration with FAU's Schmidt College of Medicine, have received a one-year, $90,000 National Science Foundation RAPID project grant to conduct research using social networks and machine learning, facilitated by molecular genetics and viral infection, for COVID-19 modeling and risk evaluation.
A new online open-access database has been developed by scientists to allow the clinical responses of more than 5 million patients to all FDA-approved drugs to be used to identify unexpected clinical harm, benefits and alternative treatment choices for individual patients, according to a study appearing July 8 in Nature Biotechnology.
Screening blood donations and molecular diagnostics for patients started in the nineties. At the beginning, the level of automation in molecular diagnostic testing was limited; most of the work had to be done manually.
› Verified 8 days ago
Mr. Trenton Cox Jones, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1375 E. 800 N., Suite 205, Orem, UT 84097 Phone: 801-418-8172 Fax: 801-404-5781 |